Consequently, it has been suggested that GSK3β plays a fundamental role in the progression of neuroinflammatory disorders, such as Alzheimer’s disease and multiple sclerosis [25]. Here, GSK3B is linked to early-onset autosomal dominant Alzheimer disease.